Vol.

No.

June 30, 2017Jun 30, 2017

Free

DOWNLOAD THE PDF

Cover Story

Biden's cancer nonprofit gets going

By Matthew Bin Han Ong

The Bidens are now official players in the realm of oncopolitics.

BSA, NCAB approve nine Cancer Moonshot concepts based on Blue Ribbon Panel recommendations

By Matthew Bin Han Ong

House appropriations bill to allow NIH to move moonshot money to FDA

By Paul Goldberg and Matthew Bin Han Ong

Buchholz, Dmitrovsky and Fontaine lose authority at MD Anderson as executive vice president positions are eliminated

By Paul Goldberg

In Brief

Ruben Mesa new director of UT Health San Antonio Cancer Center

Claire Verschraegen to lead medical oncology division at Ohio State

Gideon Blumenthal named acting deputy director of FDA Office of Hematology & Oncology Products

Robert Haile to join Samuel Oschin Comprehensive Cancer Institute

Alexander Kutikov named chief of Division of Urologic Oncology at Fox Chase

San Diego nonprofits set to receive 2017 ASTRO Survivor Circle grants

ACS and Melanoma Research Alliance to fund pilot research projects

Michael Joiner to receive Lifetime Achievement Award from European Society of Radiotherapy and Oncology

Drugs & Targets

FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer

FDA approves flow cytometry test for leukemias and lymphomas

Novartis Kisqali receives positive CHMP opinion for HR+/HER2- locally advanced or metastatic breast cancer

Novartis receives EU approval for Zykadia in ALK-positive advanced non-small cell lung cancer

FDA unveils plan to eliminate orphan designation backlog

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 44 - November 22, 2024